Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05532345Completed
Discrimination of DILI and AIH by Artificial Intelligence
Autoimmune HepatitisDrug-induced Liver Injury
PrincipalinvestigatorStart date: 2022-07-01

Research Network

Collaboration Network

10 collaborators·45 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Capital Medical University Affiliated Beijing You'an Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xinyan Zhao

Beijing Friendship Hospital

Moderately Similar
5 trials

Shared therapeutic areas:

Drug-Induced Liver DiseaseHepatitis, Autoimmune

Worked with same sponsors:

Beijing Friendship Hospital
Similarity Score30%

Zhengsheng Zou

Beijing 302 Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Drug-Induced Liver DiseaseHepatitis, Autoimmune

Worked with same sponsors:

Beijing Friendship Hospital
Similarity Score30%

Ying Sun, Dr.

The Fifth Medical Department of the PLA

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Feng Guo, Dr.

Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Qiuju Tian, Dr.

The Affiliated Hospital of Qingdao University

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Xiaoli Hu, Dr.

Heilongjiang Provicial Hospital

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Pingying Li, Dr.

Qinghai People's Hospital

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Jia Li, Dr.

Tianjin Second People's Hospital

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Xinyan Zhao, Dr.

Beijing Friendship Hospital

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Liang Wang, Dr.

Lanzhou University Affiliated Second Hospital

Related
1 trials

Shared therapeutic areas:

Hepatitis, AutoimmuneDrug-Induced Liver Disease

Worked with same sponsors:

Beijing Friendship Hospital
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05532345PrincipalInvestigator

Discrimination of DILI and AIH by Artificial Intelligence

Autoimmune HepatitisDrug-induced Liver Injury
Completed

All 1 trials loaded